Search

In this new expanded role, Avice Meehan will streamline communications across the Center and lead both Memorial Sloan Kettering’s Public Affairs and Marketing endeavors.

… Tuesday, March 12, 2013 Memorial Sloan Kettering Cancer Center has announced the appointment of Avice Meehan to Vice President of Communications and Chief Communications Officer. In this new expanded role, Meehan will streamline communications across the Center and lead both Memorial Sloan Kettering’

A new Sloan Kettering Institute program will enhance the use of chemical principles to investigate biological processes.

… Tuesday, August 18, 2015 Summary MSK has established the Chemical Biology Program to leverage the growing role of chemistry in biomedical research. Highlights This is the first new SKI program in more than a decade. Members will use chemical tools to study biology. Chemist Derek Tan will chair the new

From atherosclerosis and diabetes to liver fibrosis and osteoarthritis, senescent cells are at the root of many debilitating diseases. Scientists increasingly have them in the crosshairs.

… Wednesday, June 17, 2020 Summary Scientists at Memorial Sloan Kettering have genetically engineered immune cells to find and kill cells that contribute to diseases caused by senescence, a tissue-damaging inflammatory process. Studies in mice show that these engineered cells can kill their targets without

Dr. Sadelain received the award for his research on chimeric antigen receptors (CARs) and their use in providing tailored cancer treatment to patients.

… Tuesday, December 17, 2019   Michel Sadelain , Director of the Center for Cell Engineering and the incumbent of the Stephen and Barbara Friedman Chair at Memorial Sloan Kettering, received the 2019 International Prize from Inserm (Institut national de la santé et de la recherche médicale), or the French

A new study offers the first evidence of a drug capable of preventing lethal damage to the gastrointestinal (GI) tract caused by exposure to high levels of ionizing radiation, such as those occurring during a nuclear incident.

… Wednesday, April 4, 2012 A new study offers the first evidence of a drug capable of preventing lethal damage to the gastrointestinal (GI) tract caused by exposure to high levels of ionizing radiation, such as those occurring during a nuclear incident. There are currently no FDA-approved treatments or

Michael P. Harrington has been named Executive Vice President and Chief Financial Officer (CFO) at Memorial Sloan Kettering Cancer Center (MSK). Mr. Harrington currently serves as the Associate Chief Financial Officer at the Cleveland Clinic. His appointment concludes a national search to identify a successor for MSK’s current CFO, Michael Gutnick, who will retire after 42 years of exemplary service to MSK.

… Wednesday, April 10, 2019 Michael P. Harrington has been named Executive Vice President and Chief Financial Officer (CFO) at Memorial Sloan Kettering Cancer Center (MSK). Mr. Harrington currently serves as the Associate Chief Financial Officer at the Cleveland Clinic. His appointment concludes a national

Learn about MSK’s leadership in developing vaccines that teach the immune system to fight cancer.

… Friday, June 6, 2025 Remarkably, the idea that a patient’s own immune system could fight cancer is more than a century old. The first notion of a cancer vaccine came back in 1893. Memorial Sloan Kettering Cancer Center (MSK) bone surgeon and cancer researcher William Coley, MD, noticed that patients

Memorial Sloan Kettering Cancer Center, The Rockefeller University and Weill Cornell Medical College have formed the pioneering Tri-Institutional Therapeutics Discovery Institute, Inc. and have partnered with Takeda Pharmaceutical Company, Ltd.

… Tuesday, October 1, 2013 Pioneering Collaboration with Research-Based Global Pharmaceutical Company to Conduct Early-Stage Drug Discovery Back to top New Powerhouse for Therapeutic Research Founded with $20 Million in Generous Support from Lewis Sanders and Howard Milstein Memorial Sloan Kettering Cancer

A new study by researchers at Memorial Sloan Kettering Cancer Center finds that even the sickest cancer patients are willing and able to "self-report" symptoms using the Internet, thus supplying key data in real time to their healthcare providers.

… Thursday, November 29, 2007 Traditionally, clinicians have relied on information provided by cancer patients during their office visits as the primary means of assessing patients’ symptoms and side effects. However, potentially serious consequences could arise if important symptoms go unreported during

… Friday, March 20, 2026 March 2008 - Three Gerstner Sloan Kettering students — Eric Alonzo, Kim Png, and Ly Vu — have been awarded grants for their potential not only in pursuing meaningful scientific research but in playing a role in such diverse goals as fostering relationships between nations, ensuring